2-Apr-2026 7:30 AM CST - Business Wire Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2026 financial results after market close on Thursday, April 30, 2026. Management will hold a conference call to review the company's first quarter 2026 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will
23-Mar-2026 2:46 PM CST - Yahoo Finance How The DexCom (DXCM) Investment Story Is Shifting As Analyst Targets Diverge DexCom's fair value price target has been tweaked from US$85.85 to US$86.12 per share, a small shift that still matters if you are tracking what analysts are baking into their models. This move sits alongside Street targets that currently span from the low US$70s to the mid US$80s,
16-Mar-2026 1:44 PM CST - Yahoo Finance Singapore Here's Why You Should Hold DexCom Stock in Your Portfolio for Now DXCM gains from CGM demand, Medicare coverage expansion and its new G7 15-day sensor, but rising competition and manufacturing investments may pressure margins.
16-Mar-2026 11:39 AM CST - Yahoo Finance Is Dexcom (DXCM) Fairly Priced After Recent Share Price Pressure? If you are wondering whether DexCom at around US$64 a share looks appealing or expensive, this article breaks down what that price might actually represent for you. The stock has been under pressure recently,
9-Mar-2026 7:00 AM CST - Benzinga 3DXCM : Demystifying DexCom: Insights From 12 Analyst Reviews In the preceding three months, 12 analysts have released ratings for DexCom (NASDAQ:DXCM), presenting a wide array of perspectives from bullish to bearish. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
2-Mar-2026 3:45 PM CST - Benzinga Here's How Much You Would Have Made Owning DexCom Stock In The Last 10 Years DexCom (NASDAQ: DXCM) has outperformed the market over the past 10 years by 2.92% on an annualized basis producing an average annual return of 16.14%. Currently, DexCom has a market capitalization of $28.40 billion.
25-Feb-2026 7:30 AM CST - Business Wire Dexcom Announces Upcoming Conference Presentation DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 47th Annual Raymond James Institutional Investors Conference on Monday, March 2, 2026. The live presentation is scheduled to begin at approximately 1:05 PM EST and will be concurrently webcast. Links to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference. About DexCom, Inc. D
23-Feb-2026 6:08 AM CST - Yahoo Finance UK Did DexCom's (DXCM) Strong 2025 Results and Buybacks Just Reframe Its 2026 Growth Story? In February 2026, DexCom reported fourth-quarter 2025 sales of US$1,259.6 million and full-year 2025 sales of US$4,662 million, with net income rising to US$267.3 million for the quarter and US$836.3 million for the year,
Latest DXCM Trades by Congress Members
15-MAY-2025 - Rob Bresnahan, PA (District 8) purchased between $1,001 and $15,000.
2-Apr-2026 7:30 AM CST - Business Wire Dexcom Schedules First Quarter 2026 Earnings Release and Conference Call for April 30, 2026 at 4:30 p.m. Eastern Time DexCom, Inc. (NASDAQ:DXCM) today announced that it plans to release its first quarter 2026 financial results after market close on Thursday, April 30, 2026. Management will hold a conference call to review the company's first quarter 2026 performance starting at 4:30 p.m. (Eastern Time) on the same day. The conference call will be concurrently webcast. The link to the webcast will be available on the Dexcom investor relations website at investors.dexcom.com and will
23-Mar-2026 2:46 PM CST - Yahoo Finance How The DexCom (DXCM) Investment Story Is Shifting As Analyst Targets Diverge DexCom's fair value price target has been tweaked from US$85.85 to US$86.12 per share, a small shift that still matters if you are tracking what analysts are baking into their models. This move sits alongside Street targets that currently span from the low US$70s to the mid US$80s,
16-Mar-2026 1:44 PM CST - Yahoo Finance Singapore Here's Why You Should Hold DexCom Stock in Your Portfolio for Now DXCM gains from CGM demand, Medicare coverage expansion and its new G7 15-day sensor, but rising competition and manufacturing investments may pressure margins.
16-Mar-2026 11:39 AM CST - Yahoo Finance Is Dexcom (DXCM) Fairly Priced After Recent Share Price Pressure? If you are wondering whether DexCom at around US$64 a share looks appealing or expensive, this article breaks down what that price might actually represent for you. The stock has been under pressure recently,
9-Mar-2026 7:00 AM CST - Benzinga 3DXCM : Demystifying DexCom: Insights From 12 Analyst Reviews In the preceding three months, 12 analysts have released ratings for DexCom (NASDAQ:DXCM), presenting a wide array of perspectives from bullish to bearish. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
2-Mar-2026 3:45 PM CST - Benzinga Here's How Much You Would Have Made Owning DexCom Stock In The Last 10 Years DexCom (NASDAQ: DXCM) has outperformed the market over the past 10 years by 2.92% on an annualized basis producing an average annual return of 16.14%. Currently, DexCom has a market capitalization of $28.40 billion.
25-Feb-2026 7:30 AM CST - Business Wire Dexcom Announces Upcoming Conference Presentation DexCom, Inc. (NASDAQ:DXCM) today announced that management will present an update on the company at the 47th Annual Raymond James Institutional Investors Conference on Monday, March 2, 2026. The live presentation is scheduled to begin at approximately 1:05 PM EST and will be concurrently webcast. Links to the webcast will be available on the Dexcom Investor Relations website at investors.dexcom.com and will be archived there for future reference. About DexCom, Inc. D
23-Feb-2026 6:08 AM CST - Yahoo Finance UK Did DexCom's (DXCM) Strong 2025 Results and Buybacks Just Reframe Its 2026 Growth Story? In February 2026, DexCom reported fourth-quarter 2025 sales of US$1,259.6 million and full-year 2025 sales of US$4,662 million, with net income rising to US$267.3 million for the quarter and US$836.3 million for the year,
